-
Exome Sequencing of Pleuropulmonary Blastoma
Study
phs000543
-
Hereditary Cancer Predisposition Syndromes and Uveal Melanoma
Study
phs001943
-
RB1 Loss Triggers Dependence on ESRRG in Retinoblastoma
Study
phs002859
-
Exceptional Responders Initiative
Study
phs001145
-
A Single Cell Atlas of MMRd and MMRp Colorectal Cancer
Study
phs002407
-
PDAC Prognosis Biomarkers in Genomic and Transcriptomic Molecular Data
Study
phs002347
-
The Genomic Complexity of Primary Human Prostate Cancer
Study
phs000330
-
Discovery of Non-ETS Gene Fusions in Human Prostate Cancer using Next Generation RNA Sequencing
Study
phs000310
-
Functional Significance of Prostate Cancer Risk-SNPs
Study
phs000985
-
eMERGE Network Phase III: HRC SNV and 1000 Genomes SV Imputed Array Data of 105,000 Participants
Study
phs001584
-
The African American Breast Cancer Epidemiology and Risk (AMBER) Consortium Study
Study
phs000669
-
Kids First and INCLUDE: Down Syndrome, Heart Defects, and Acute Lymphoblastic Leukemia
Study
phs002330
-
Gabriella Miller Kids First Pediatric Research Program in Whole Genome Sequencing of African and Asian Orofacial Clefts Case-Parent Triads
Study
phs001997
-
Integrative Tissue Analysis of Men with Prostate Cancer
Study
phs001813
-
Prostate Cancer Genome Sequencing Project
Study
phs000447
-
Kidney Two-Hit Mapping
Study
phs001971
-
Tumor Mutation Burden, Expressed Neoantigen and Immune Microenvironment in Diffuse Gliomas
Study
phs002653
-
Kids First Pediatric Research Study in Familial Predisposition to Hematopoietic Malignancies (SJFAMILY-HM)
Study
phs001738
-
A Genome-Wide Association Study of Lung Cancer Risk
Study
phs000336
-
Neoadjuvant Trastuzumab Response in Breast Cancer
Study
phs001291
-
APOLLO1: Proteogenomic Analysis of Lung Adenocarcinoma
Study
phs003011
-
Characterization of Structural Variants in Acute Myeloid Leukemia Patients
Study
phs001847
-
Combined Targeting of CDK4/6 and HER2 Signaling in Orthotopic Patient-Derived Xenografts of HER2-Positive Breast Cancer Brain Metastases
Study
phs002482
-
Tumor Infiltrating Lymphocytes (TIL) Recognize Unique Somatic Mutations and Mediate Objective Clinical Responses in Metastatic Breast Cancer
Study
phs002735
-
HCI-PDX Trial Center for Breast Cancer Therapy
Study
phs002479